503 related articles for article (PubMed ID: 25865467)
21. Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries.
Levin A; Wang SA; Levin C; Tsu V; Hutubessy R
PLoS One; 2014; 9(6):e101114. PubMed ID: 24968002
[TBL] [Abstract][Full Text] [Related]
22. The costs of introducing a malaria vaccine through the expanded program on immunization in Tanzania.
Hutton G; Tediosi F
Am J Trop Med Hyg; 2006 Aug; 75(2 Suppl):119-30. PubMed ID: 16931823
[TBL] [Abstract][Full Text] [Related]
23. The value of tailoring vial sizes to populations and locations.
Wedlock PT; Mitgang EA; Haidari LA; Prosser W; Brown ST; Krudwig K; Siegmund SS; DePasse JV; Bakal J; Leonard J; Welling J; Steinglass R; Mwansa FD; Phiri G; Lee BY
Vaccine; 2019 Jan; 37(4):637-644. PubMed ID: 30578087
[TBL] [Abstract][Full Text] [Related]
24. The benefits of redesigning Benin's vaccine supply chain.
Brown ST; Schreiber B; Cakouros BE; Wateska AR; Dicko HM; Connor DL; Jaillard P; Mvundura M; Norman BA; Levin C; Rajgopal J; Avella M; Lebrun C; Claypool E; Paul P; Lee BY
Vaccine; 2014 Jul; 32(32):4097-103. PubMed ID: 24814550
[TBL] [Abstract][Full Text] [Related]
25. Can thermostable vaccines help address cold-chain challenges? Results from stakeholder interviews in six low- and middle-income countries.
Kristensen DD; Lorenson T; Bartholomew K; Villadiego S
Vaccine; 2016 Feb; 34(7):899-904. PubMed ID: 26778422
[TBL] [Abstract][Full Text] [Related]
26. Equity and immunization supply chain in Madagascar.
van den Ent MMVX; Yameogo A; Ribaira E; Hanson CM; Ratoto R; Rasolomanana S; Foncha C; Gasse F
Vaccine; 2017 Apr; 35(17):2148-2154. PubMed ID: 28364923
[TBL] [Abstract][Full Text] [Related]
27. The cost-effectiveness of alternative polio immunization policies in South Africa.
Griffiths UK; Botham L; Schoub BD
Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
[TBL] [Abstract][Full Text] [Related]
28. Integration of vaccine supply chains with other health commodity supply chains: a framework for decision making.
Yadav P; Lydon P; Oswald J; Dicko M; Zaffran M
Vaccine; 2014 Nov; 32(50):6725-32. PubMed ID: 25446826
[TBL] [Abstract][Full Text] [Related]
29. Comparative cost models of a liquid nitrogen vapor phase (LNVP) cold chain-distributed cryopreserved malaria vaccine vs. a conventional vaccine.
Garcia CR; Manzi F; Tediosi F; Hoffman SL; James ER
Vaccine; 2013 Jan; 31(2):380-6. PubMed ID: 23146676
[TBL] [Abstract][Full Text] [Related]
30. Optimized supply chain model reduces health system costs in DRC.
Thomas D; Motomoke E; Crawford J; Defawe O; Makaya A; Ngwato JW; Bompongo J; Monzembela J; Ailstock G; Bancroft E; Magadzire B; Baabo D; Watson N
Vaccine; 2021 Jul; 39(30):4166-4172. PubMed ID: 34127290
[TBL] [Abstract][Full Text] [Related]
31. Incremental system costs of introducing combined DTwP-hepatitis B-Hib vaccine into national immunization services in Ethiopia.
Griffiths UK; Korczak VS; Ayalew D; Yigzaw A
Vaccine; 2009 Feb; 27(9):1426-32. PubMed ID: 19146901
[TBL] [Abstract][Full Text] [Related]
32. Estimating the costs of implementing the rotavirus vaccine in the national immunisation programme: the case of Malawi.
Madsen LB; Ustrup M; Hansen KS; Nyasulu PS; Bygbjerg IC; Konradsen F
Trop Med Int Health; 2014 Feb; 19(2):177-85. PubMed ID: 24314006
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of house-to-house versus fixed-site oral poliovirus vaccine delivery strategies in a mass immunization campaign in Egypt.
Linkins RW; Mansour E; Wassif O; Hassan MH; Patriarca PA
Bull World Health Organ; 1995; 73(5):589-95. PubMed ID: 8846484
[TBL] [Abstract][Full Text] [Related]
34. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
[TBL] [Abstract][Full Text] [Related]
35. Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts.
Gandhi G; Lydon P
BMC Public Health; 2014 Jan; 14():67. PubMed ID: 24450832
[TBL] [Abstract][Full Text] [Related]
36. Producing Standardized Country-Level Immunization Delivery Unit Cost Estimates.
Portnoy A; Vaughan K; Clarke-Deelder E; Suharlim C; Resch SC; Brenzel L; Menzies NA
Pharmacoeconomics; 2020 Sep; 38(9):995-1005. PubMed ID: 32596785
[TBL] [Abstract][Full Text] [Related]
37. Preliminary results from direct-to-facility vaccine deliveries in Kano, Nigeria.
Aina M; Igbokwe U; Jegede L; Fagge R; Thompson A; Mahmoud N
Vaccine; 2017 Apr; 35(17):2175-2182. PubMed ID: 28364927
[TBL] [Abstract][Full Text] [Related]
38. The impact of introducing new vaccines on the health system: case studies from six low- and middle-income countries.
Burchett HE; Mounier-Jack S; Torres-Rueda S; Griffiths UK; Ongolo-Zogo P; Rulisa S; Edengue JM; Chavez E; Kitaw Y; Molla M; Konate M; Gelmon L; Onyango-Ouma W; Lagarde M; Mills A
Vaccine; 2014 Nov; 32(48):6505-12. PubMed ID: 25261379
[TBL] [Abstract][Full Text] [Related]
39. [Estimated costs of the expanded program of immunization in the health district of Grand Bassam, Cote d'Ivoire].
Douba A; Dagnan SN; Zengbe-Acray P; Aka J; Lépri-Aka N
Sante Publique; 2011; 23(2):113-21. PubMed ID: 21896225
[TBL] [Abstract][Full Text] [Related]
40. Dual-chamber injection device for measles-rubella vaccine: The potential impact of introducing varying sizes of the devices in 3 countries.
Wedlock PT; Mitgang EA; Siegmund SS; DePasse J; Bakal J; Leonard J; Welling J; Brown ST; Lee BY
Vaccine; 2018 Sep; 36(39):5879-5885. PubMed ID: 30146404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
